- Cancer PHGKB -
Last Posted: Jun 06, 2019
- Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Kahn Ryan M et al. Cancer 2019 May
- Is immunohistochemistry-based screening for Lynch syndrome in endometrial cancer effective? The consent's the thing.
Gudgeon James M et al. Gynecologic oncology 2019 May
- Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas Dolors et al. Virchows Archiv : an international journal of pathology 2019 May 474(5) 585-598
- The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
Ryan N A J et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 May
- Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes.
Tian Wenjuan et al. International journal of cancer 2019 May
- Genome-wide association studies of endometrial cancer: Latest developments and future directions.
O'Mara Tracy A et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Apr
- Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population.
Miller Jason E, et al. BMC medical genomics 2019 5 0. (1) 59
- [A prospective cohort study about the screening tests of mismatch repair protein and clinical criteria for Lynch syndrome associated endometrial carcinoma].
Chao X P et al. Zhonghua yi xue za zhi 2019 Apr 99(15) 1178-1183
- Clinical and Cost Effectiveness of Two New Lynch Syndrome Case Finding Protocols in Endometrial Cancer Population Contrasted with the IHC-based Protocol
JM Gudgeon et al, BioRXIV, April 18, 2019
- Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow Robert A et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2019 Jan 38 Suppl 1S64-S74
- Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins: Significance of Indeterminate Result and Correlation With Mutational Studies.
Sarode Venetia R et al. Archives of pathology & laboratory medicine 2019 Mar
- A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?
Ryan Neil A J et al. Frontiers in oncology 2019 961
- Impact of molecular testing in clinical practice in gynecologic cancers.
Huang Marilyn et al. Cancer medicine 2019 Mar
- [Lynch Syndrome:Report of One Case and Literature Review].
Guo Yan-Ping et al. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2018 Jun 40(3) 432-435
- A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu Yu-Shen et al. Gene 2019 Feb
- CDC Information (1)
- NIH Information (1)
- CDC Genomics Publications (1)
- Human Genome Epidemiologic Studies (508)
- GWAS Studies (10)
- Human Genomics Translation/Implementation Studies (113)
- Genomic Tests Evidence Synthesis (11)
- Genomic Tests Guidelines (8)
- Tier-Classified Guidelines (6)
- State Public Health Genomics Programs (73)
- Reviews/Commentaries (43)
- Tools/Methods (3)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 19, 2019
- Content source: